首页> 外文期刊>American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons >NIM811, a mitochondrial permeability transition inhibitor, prevents mitochondrial depolarization in small-for-size rat liver grafts.
【24h】

NIM811, a mitochondrial permeability transition inhibitor, prevents mitochondrial depolarization in small-for-size rat liver grafts.

机译:NIM811是一种线粒体通透性转换抑制剂,可防止小型大鼠肝移植物中的线粒体去极化。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

ATP decreases markedly in small-for-size liver grafts. This study tested if the mitochondrial permeability transition (MPT) underlies dysfunction of small-for-size livers. Half-size livers were implanted into recipients of about twice the donor weight, resulting in quarter-size liver grafts. NIM811 (5 microM), a nonimmunosuppressive MPT inhibitor was added to the storage solutions. Mitochondrial polarization and cell death were assessed by confocal microscopy of rhodamine 123 (Rh123) and propidium iodide (PI), respectively. After quarter-size transplantation, alanine aminotransferase (ALT), serum bilirubin and necrosis all increased. NIM811 blocked these increases by >70%. After 38 h, BrdU labeling, a marker of cell proliferation and graft weight increase were 3% and 5%, respectively, which NIM811 increased to 30% and 42%. NIM811 also increased survival of quarter-size grafts. In sham-operated livers, hepatocytes exhibited punctate Rh123 fluorescence. By contrast, in quarter-size grafts at 18 h after implantation, mitochondria of most hepatocytes did not take up Rh123, indicating mitochondrial depolarization. Nearly all hepatocytes not taking up Rh123 continued to exclude PI at 18 h, indicating that depolarization preceded cell death. NIM811 and free radical-scavenging polyphenols strongly attenuated mitochondrial depolarization. In conclusion, mitochondria depolarized after quarter-size liver transplantation. NIM811 decreased injury and stimulated regeneration, probably by inhibiting free radical-dependent MPT onset.
机译:在小型肝移植物中,ATP明显降低。这项研究测试了线粒体通透性转变(MPT)是否是小型肝脏功能障碍的基础。将一半大小的肝脏植入约两倍于供体重量的受者体内,形成四分之一大小的肝脏。 NIM811(5 microM),一种非免疫抑制性MPT抑制剂被添加到存储溶液中。分别通过若丹明123(Rh123)和碘化丙啶(PI)的共聚焦显微镜评估线粒体极化和细胞死亡。四分之一大小的移植后,丙氨酸转氨酶(ALT),血清胆红素和坏死均增加。 NIM811阻止了这些增长超过70%。 38小时后,BrdU标记,细胞增殖和移植物重量增加的标记分别为3%和5%,其中NIM811增加至30%和42%。 NIM811还增加了四分之一大小的移植物的存活率。在假手术的肝脏中,肝细胞显示出点状的Rh123荧光。相比之下,在植入后18小时的四分之一大小的移植物中,大多数肝细胞的线粒体并未吸收Rh123,表明线粒体去极化。几乎所有未摄取Rh123的肝细胞在18 h仍继续排除PI,表明去极化先于细胞死亡。 NIM811和清除自由基的多酚可强烈减弱线粒体的去极化作用。总之,四分之一大小的肝移植后线粒体去极化。 NIM811可以通过抑制自由基依赖性MPT的发作来减少损伤并刺激再生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号